A high density of CD8+ TRM cells within the tumor was found to be associated with better patient survival in multiple cancers, including melanoma, glioma, non-small cell lung carcinoma (NSCLC), and ovarian, bladder and breast cancers (15, 16, 18, 20–25). Here, CD8A is linked to non-small cell lung carcinoma.